Four questions.
A clearer decision.

Does it help?

We look for relevant trials, systematic reviews, and professional guidelines. What was compared, who participated, how long the benefit lasted, and how large it was matter more than a positive headline.

Human outcomes are different from laboratory or animal findings. One product, joint, or patient group does not establish the result for another.

What are the risks?

We explain reported harms, uncertainty, and limitations. A small study without reported side effects cannot establish long-term safety. Funding, study design, and conflicting results are considered alongside the findings.

What is FDA-approved or cleared?

We check the exact product and its intended use. Approval of a medicine and clearance of a device are different regulatory pathways. Neither should be expanded into claims beyond the reviewed indication. Compounded drugs are not FDA-approved.

Some care, such as exercise or a food pattern, is not subject to FDA approval as a treatment. That does not determine its clinical value.

Will insurance cover it?

Coverage depends on the plan, indication, location, and clinical criteria. Medicare coverage does not establish effectiveness, and lack of coverage does not by itself establish ineffectiveness. Cash ranges are illustrative, not provider quotes.

Review and corrections

We link the sources used for each summary and keep clinical effectiveness, regulatory status, and coverage separate. Dates identify source checks; they do not imply that every cited guideline was published recently. Substantive changes should identify the affected page, source, and reason in our editorial record.

Formal clinical sign-off is recorded only after a named clinician reviews the specific page. If information here differs from your care team’s advice, bring the page and its references to that conversation. This website has no monitored corrections inbox or clinical messaging service.